Veterinary Medicines

NOBIVAC GUMBORO+ND ΕΝΕΣΙΜΟ ΕΝΑΙΩΡΗΜΑ

Authorised
  • Newcastle disease virus, strain Clone 30, Inactivated
  • Infectious bursal disease virus, strain D78, Live
Download as PDF

Product identification

Medicine name:
NOBIVAC GUMBORO+ND ΕΝΕΣΙΜΟ ΕΝΑΙΩΡΗΜΑ
Active substance:
  • Newcastle disease virus, strain Clone 30, Inactivated
  • Infectious bursal disease virus, strain D78, Live
Target species:
  • Chicken
Route of administration:
  • Intramuscular use
  • Subcutaneous use

Product details

Active substance and strength:
  • Newcastle disease virus, strain Clone 30, Inactivated
    50.00
    50% Protective Dose
    /
    0.50
    millilitre(s)
  • Infectious bursal disease virus, strain D78, Live
    12.50
    log2 virus neutralising unit(s)
    /
    0.50
    millilitre(s)
Pharmaceutical form:
  • Suspension for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Chicken
      • Meat and offal
        0
        day
  • Subcutaneous use
    • Chicken
      • Meat and offal
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI01AA11
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Greece
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Complete application (stand-alone)
Marketing authorisation holder:
  • Intervet Hellas A.E.
Marketing authorisation date:
Manufacturing sites for batch release:
  • INTERVET INTERNATIONAL B.V.
Responsible authority:
  • National Organization For Medicines
Authorisation number:
  • 7047/Κ2170/09-05-1985/K-0028101
Date of authorisation status change:
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."